Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the efficacy of Buscopan® (hyoscine butylbromide) in
comparison to 654-II (anisodamine)in acute gastric or intestinal spasm-like pain.